103 related articles for article (PubMed ID: 3096919)
1. Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
Ebina T; Kohya H; Yamaguchi T; Ishida N
Jpn J Cancer Res; 1986 Oct; 77(10):1034-42. PubMed ID: 3096919
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor effect of Cepharanthin in the double grafted tumor system].
Ebina T; Ishikawa K; Murata K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
Ebina T; Shishido K; Murata K
Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
Ebina T; Kohya H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of interleukin-1 beta in the double grafted tumor system.
Ebina T; Ishikawa K
Jpn J Cancer Res; 1989 Jun; 80(6):570-6. PubMed ID: 2503477
[TBL] [Abstract][Full Text] [Related]
6. [Differences of antitumor effect of various BRMs by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1812-6. PubMed ID: 1877822
[TBL] [Abstract][Full Text] [Related]
8. [Regional adoptive immunotherapy using activated lymphocytes].
Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].
Ebina T; Kohya H; Inoue H; Aso H
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1841-6. PubMed ID: 2439019
[TBL] [Abstract][Full Text] [Related]
10. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
[TBL] [Abstract][Full Text] [Related]
11. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
Kohya H; Ebina T; Yamaguchi T; Ishida N
Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
Ebina T; Kohya H
Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
[TBL] [Abstract][Full Text] [Related]
13. [Effects of levamisole on methylcholanthrene-induced tumor. I. Its antitumor effect and immunological mechanism].
Gomi K; Morimoto M; Nomoto K
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1262-8. PubMed ID: 7184454
[TBL] [Abstract][Full Text] [Related]
14. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
[TBL] [Abstract][Full Text] [Related]
15. Curative intravenous adoptive immunotherapy of Meth A murine sarcoma. A histologic and immunohistochemical assessment.
Reichert CM; Rosenstein M; Von Glatz J; Hsu SM; Rosenberg SA
Lab Invest; 1985 Mar; 52(3):304-13. PubMed ID: 3974201
[TBL] [Abstract][Full Text] [Related]
16. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
[TBL] [Abstract][Full Text] [Related]
17. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
18. [Effect of combined immunotherapy using two different BRMs; OK-432 and IL-2-cultured lymphocytes].
Kan N; Hori T; Ohgaki K; Inamoto T; Kodama H; Tobe T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1298-306. PubMed ID: 3488027
[TBL] [Abstract][Full Text] [Related]
19. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.
Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N
Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation.
Homma S; Sagawa Y; Komita H; Koido S; Nagasaki E; Ryoma Y; Okamoto M
Cancer Immunol Immunother; 2007 Aug; 56(8):1265-74. PubMed ID: 17219148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]